Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-05-03

Clinical Trial Update: Combination Diuretic Therapy for Acute Decompensated Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating combination diuretic therapy for acute decompensated heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ochsner Health System | Conditions: Acute Decompensated Heart Failure | Phase 4 | Status: WITHDRAWN